Innovation Saving Lives

We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch™, based on the latest advances in gene expression,non-coding RNA and epigenetics.

EpiSwitch™ biomarkers based on chromosomal conformation signatures are a critical cog in personalised medicine.

Technology to select the right drug at the right dose at the right time for the right patient.

To learn more about the science,read our White Paper

Recent Publications on Chromosome Conformation Signatures


Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.

Engmann O et. al.
Biol Psychiatry
https://www.ncbi.nlm.nih.gov/pubmed/28577753

Nucleome Analysis Reveals Structure-function Relationships for Colon Cancer.

Seaman L et. al.
Mol Cancer Res.
https://www.ncbi.nlm.nih.gov/pubmed/28258094

Topologically associated domains: a successful scaffold for the evolution of gene regulation in animals.

Acemel RD et. al.
Wiley Interdiscip Rev Dev Biol.
https://www.ncbi.nlm.nih.gov/pubmed/28251841

Software tools for visualizing Hi-C data.

Yardimici GG et. al.
Genome Biology
https://www.ncbi.nlm.nih.gov/pubmed/28159004

Capturing genomic relationships that matter.

Osborne CS et. al.
Chromosome Research
https://www.ncbi.nlm.nih.gov/pubmed/28078515